webinar register page

Webinar banner
Forum LIVE: Rationale for treatment selections in inflammatory arthritis

Jul 6, 2022 05:00 PM in London

* Required information


Janet Pope
Professor of Medicine in the Division of Rheumatology @University of Western Ontario Schulich School of Medicine
Professor Pope is a Professor of Medicine in the Division of Rheumatology at the University of Western Ontario, Schulich School of Medicine, and Division Head in Rheumatology at St Joseph's Health Care in London, Ontario, Canada. She obtained her Masters degree in Public Health and Fellowship in Rheumatology from Boston University. She then completed a Canadian Arthritis Society Research Fellow in Scleroderma. She is a section editor of Arthritis & Rheumatology, and on the Editorial Boards of Journal of Rheumatology, Nature Reviews Rheumatology, Lancet Rheumatology, RMD Open. Her research includes epidemiologic studies in scleroderma, systemic lupus erythematosus (SLE) and RA, including outcome measurements, clinical trials and disease manifestations. She has published over 500 peer-reviewed articles, 15 chapters, 600 abstracts, and several Cochrane meta-analysis reviews.
Philip Mease
Director of Rheumatology Research @Swedish Medical Center
Philip Mease is a Clinical Professor at the University of Washington School of Medicine, and Director of Rheumatology Research at the Swedish Medical Center in Seattle, Washington, US. Dr Mease obtained his undergraduate and medical degrees at Stanford University Medical School, and he completed his residency in internal medicine at the University of Washington’s School of Medicine, where he also served as Chief Resident and Fellow in Rheumatology. As well as conducting clinical trials on emerging therapies for rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, osteoarthritis, and lupus, he also conducts research in disease state metrics and is the Co-chair of three working groups for OMERACT on psoriatic arthritis, fibromyalgia, and single-joint assessment. Dr Mease is also a member of the Soluble Biomarker working group. Dr Mease is a founding organiser and President of GRAPPA a member of SPARTAN, and a member of TREG.
Eric M. Ruderman
Associate Chief, Clinical Affairs for the Division of Rheumatology @Northwestern University
Dr Ruderman is currently a Professor of Medicine and Associate Chief of Clinical Affairs for the Division of Rheumatology at Northwestern University. In addition to his clinical roles, Dr. Ruderman manages clinical trials in rheumatoid arthritis and other inflammatory arthritides. As a result of his research interests, Dr. Ruderman consults regularly on the development and utilization of rheumatologic therapeutics as well as serving on the data safety monitoring boards for industry and NIH-sponsored trials. Dr. Ruderman is a member of the Communications and Marketing Committee and the Drug Safety subcommittee of ACR and is co-editor of the ACR’s Hotline newsletter. He is also on the scientific advisory committee for the Coalition of Rheumatology Researchers of North America (CORRONA) and is a member of the editorial boards of Rheumatology and the International Journal of Advances in Rheumatology.